Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Niramas Utama Tbk. (JELI) Price & Performance

Cipta Sarana Medika Tbk.Trade
Niramas Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Niramas Utama Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume). The key difference: Niramas Utama Tbk. is far larger — about 5.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 10.75M). Which is the better fit depends on your goals.

DKHHJELI
Market Cap
160.67B848.22B
Volume
14.05M10.75M
Lot
140.49K107.48K
Turnover
899.67M6.9B
Average Price
64.04642.24
Value
899.67M6.9B
Indicative Equilibrium Price
64635
Indicative Equilibrium Volume
1006.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
JELI
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Niramas Utama Tbk.

PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama

Read more on JELI